Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Blood

Volumn 123, Issue 8, 2014, Pages 1214-1217

  Scott, David W ^a   Wright, George W ^b   Williams, P Mickey ^c   Lih, Chih Jian ^c   Walsh, William ^c   Jaffe, Elaine S ^b   Rosenwald, Andreas ^d   Campo, Elias ^e   Chan, Wing C ^f   Connors, Joseph M ^a   Smeland, Erlend B ^g   Mottok, Anja ^a   Braziel, Rita M ^h   Ott, German ⁱ   Delabie, Jan ^j   Tubbs, Raymond R ^k   Cook, James R ^k   Weisenburger, Dennis D ^l   Greiner, Timothy C ^f   Glinsmann Gibson, Betty J ^m   Fu, Kai ^f   Staudt, Louis M ^b   Gascoyne, Randy D ^a   Rimsza, Lisa M ^m   more..

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b NATIONAL CANCER INSTITUTE   (United States)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e HOSPITAL CLÍNIC   (Spain)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^g UNIVERSITY OF OSLO   (Norway)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ ROBERT BOSCH HOSPITAL   (Germany)

^j OSLO UNIVERSITY HOSPITAL   (Norway)

^k LERNER RESEARCH INSTITUTE   (United States)

^l CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^m UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN; FIXATIVE; TRANSCRIPTOME;

ARTICLE; CELL OF ORIGIN; CELL TYPE; FORMALIN FIXED PARAFFIN EMBEDDED TISSUE; GENE EXPRESSION; GENE EXPRESSION ASSAY; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOMA CELL; PRIORITY JOURNAL; TISSUE MICROARRAY; TISSUES; VALIDATION STUDY; ADOLESCENT; ADULT; AGED; BIOPSY; CELL LINEAGE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEALTH CARE FACILITY; MALE; MIDDLE AGED; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELL LINEAGE; FEMALE; FIXATIVES; FORMALDEHYDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; TISSUE BANKS; TRANSCRIPTOME; YOUNG ADULT;

EID: 84899136028     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-11-536433     Document Type: Article

References (22)

1. Swerdlow SH, Campo E, Harris NL, et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. Lyon, France: IARC Press; 2008.
2. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503-511. (Pubitemid 30082188)
3. Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA. 2003;100(17):9991-9996. (Pubitemid 37087056)
4. Shaffer AL III, Young RM, Staudt LM. Pathogenesis of human B cell lymphomas. Annu Rev Immunol. 2012;30:565-610.
5. Rosenwald A, Wright G, Chan WC, et al Lymphoma/Leukemia Molecular Profiling Project. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937-1947.
6. Lenz G, Wright G, Dave SS, et al Lymphoma/Leukemia Molecular Profiling Project. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359(22):2313-2323.
7. Dunleavy K, Pittaluga S, Czuczman MS, et al. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood. 2009;113(24):6069-6076.
8. Thieblemont C, Briere J, Mounier N, et al. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study. J Clin Oncol. 2011;29(31):4079-4087.
9. Young RM, Staudt LM. Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov. 2013;12(3):229-243.
10. Gutiérrez-García G, Cardesa-Salzmann T, Climent F, et al; Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB). Geneexpression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood. 2011;117(18):4836-4843.
11. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275-282. (Pubitemid 38029949)
12. Choi WW, Weisenburger DD, Greiner TC, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009;15(17):5494-5502.
13. Meyer PN, Fu K, Greiner TC, et al. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol. 2011;29(2):200-207.
14. Rimsza LM, Leblanc ML, Unger JM, et al. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2008;112(8):3425-3433.
15. Rimsza LM, Wright G, Schwartz M, et al. Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues. Clin Cancer Res. 2011;17(11):3727-3732.
16. Barrans SL, Crouch S, Care MA, et al. Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome. Br J Haematol. 2012;159(4):441-453.
17. Scott DW, Chan FC, Hong F, et al. Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. J Clin Oncol. 2013;31(6):692-700.
18. Masqué-Soler N, Szczepanowski M, Kohler CW, Spang R, Klapper W. Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens. Blood. 2013;122(11):1985-1986.
19. Geiss GK, Bumgarner RE, Birditt B, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008;26(3):317-325. (Pubitemid 351355126)
20. Cheson BD, Pfistner B, Juweid ME, et al International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579-586. (Pubitemid 350002966)
21. de Jong D, Rosenwald A, Chhanabhai M, et al Lunenburg Lymphoma Biomarker Consortium. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications-a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol. 2007;25(7):805-812. (Pubitemid 350002880)
22. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329(14):987-994.